ZA856695B - Cis-platinum complexes with a pentaerythritol derivative as the ligand,a process for their preparation and a pharmaceutical agent containing these compounds - Google Patents

Cis-platinum complexes with a pentaerythritol derivative as the ligand,a process for their preparation and a pharmaceutical agent containing these compounds

Info

Publication number
ZA856695B
ZA856695B ZA856695A ZA856695A ZA856695B ZA 856695 B ZA856695 B ZA 856695B ZA 856695 A ZA856695 A ZA 856695A ZA 856695 A ZA856695 A ZA 856695A ZA 856695 B ZA856695 B ZA 856695B
Authority
ZA
South Africa
Prior art keywords
compounds
represent
group
sulfate
carbon atoms
Prior art date
Application number
ZA856695A
Other languages
English (en)
Inventor
Cehek Kolar
Hans Peter Kraemer
Konrad Dehmel
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6244515&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA856695(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of ZA856695B publication Critical patent/ZA856695B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA856695A 1984-09-03 1985-09-02 Cis-platinum complexes with a pentaerythritol derivative as the ligand,a process for their preparation and a pharmaceutical agent containing these compounds ZA856695B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843432320 DE3432320A1 (de) 1984-09-03 1984-09-03 Cis-platin-komplexe mit einem pentaerythritderivat als liganden, verfahren zu ihrer herstellung und diese verbindungen enthaltendes pharmazeutisches mittel

Publications (1)

Publication Number Publication Date
ZA856695B true ZA856695B (en) 1986-04-30

Family

ID=6244515

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA856695A ZA856695B (en) 1984-09-03 1985-09-02 Cis-platinum complexes with a pentaerythritol derivative as the ligand,a process for their preparation and a pharmaceutical agent containing these compounds

Country Status (8)

Country Link
US (1) US4730069A (ja)
EP (1) EP0174542B1 (ja)
JP (1) JPH0730105B2 (ja)
AT (1) ATE44277T1 (ja)
CA (1) CA1268599A (ja)
DE (2) DE3432320A1 (ja)
ES (1) ES8604855A1 (ja)
ZA (1) ZA856695B (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880790A (en) * 1986-01-31 1989-11-14 American Cyanamid Company (Gem-heterocyclodimethanamine-N,N')platinum complexes
US4797393A (en) * 1986-07-25 1989-01-10 University Of Vermont And State Agricultural College Bis-platinum complexes as chemotherapeutic agents
US5107007A (en) * 1989-09-01 1992-04-21 The University Of Vermont And State Agricultural College Bis-platinum complexes as chemotherapeutic agents
DE3630497A1 (de) * 1986-09-08 1988-03-10 Behringwerke Ag Cis-platin-komplexe, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
US4870070A (en) * 1987-08-10 1989-09-26 American Cyanamid Company Water soluble platinum complexes of novel malonate derivatives
AT390065B (de) * 1987-10-08 1990-03-12 Behringwerke Ag Cis-platin-komplexe, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
IT1216687B (it) * 1988-04-01 1990-03-08 Boehringer Biochemia Srl Complessi di platino (ii), loro preparazione e impiego come antitumorali.
US4931553A (en) * 1988-05-11 1990-06-05 Gill Devinder S Platinum-polymer complexes and their use as antitumor agents
FR2635317B1 (fr) * 1988-08-11 1990-10-19 Norsolor Sa Hydrures de platine de structure bimetallique pontee, leur procede de preparation et leur application a la catalyse de reactions chimiques
DE3834098A1 (de) * 1988-10-07 1990-04-19 Behringwerke Ag Cis-platin-komplexe mit einem 1,3-diaminopropan-derivat als liganden, verfahren zu ihrer herstellung und diese verbindung enthaltende pharmazeutische mittel
JPH02275891A (ja) * 1988-12-29 1990-11-09 Tsumura & Co 新規な複核白金錯体および該錯体を有効成分とする抗腫瘍剤
CA2106679C (en) * 1991-03-23 1996-01-09 Dae-Kee Kim Novel platinum (ii) complex and processes for preparing the same
KR940010295B1 (ko) * 1991-07-05 1994-10-22 한국과학기술연구원 신규 항암성 백금 착화합물 유도체 및 그 제조방법
US5409915A (en) * 1993-09-14 1995-04-25 The University Of Vermont And State Agricultural College Bis-platinum (IV) complexes as chemotherapeutic agents
US6147168A (en) * 1995-03-06 2000-11-14 Ethicon, Inc. Copolymers of absorbable polyoxaesters
US5597579A (en) * 1995-03-06 1997-01-28 Ethicon, Inc. Blends of absorbable polyoxaamides
US5618552A (en) * 1995-03-06 1997-04-08 Ethicon, Inc. Absorbable polyoxaesters
US5464929A (en) * 1995-03-06 1995-11-07 Ethicon, Inc. Absorbable polyoxaesters
US5607687A (en) * 1995-03-06 1997-03-04 Ethicon, Inc. Polymer blends containing absorbable polyoxaesters
US5648088A (en) * 1995-03-06 1997-07-15 Ethicon, Inc. Blends of absorbable polyoxaesters containing amines and/or amide groups
US6403655B1 (en) 1995-03-06 2002-06-11 Ethicon, Inc. Method of preventing adhesions with absorbable polyoxaesters
US5962023A (en) 1995-03-06 1999-10-05 Ethicon, Inc. Hydrogels containing absorbable polyoxaamides
ATE413390T1 (de) * 2001-12-31 2008-11-15 Pfaendler Hans Rudolf Langkettige fettalkoholsubstituenten in mitteln gegen krebs
JP4899385B2 (ja) * 2005-09-06 2012-03-21 宇部興産株式会社 ３−アミノメチルオキセタン化合物の製法
DE102007012284A1 (de) 2007-03-16 2008-09-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
AU2020404975B2 (en) 2019-12-18 2024-03-28 Haleon Us Holdings Llc Tamper-proof and controlled dosing container

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7903361L (sv) * 1978-04-20 1979-10-21 Johnson Matthey Co Ltd Kompositioner innehallande platina
NL7807334A (nl) * 1978-07-06 1980-01-08 Tno Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel.
NL8204067A (nl) * 1982-10-21 1984-05-16 Tno Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platinadiaminecomplex voor de behandeling van kanker, alsmede aldus verkregen gevormd geneesmiddel.

Also Published As

Publication number Publication date
ATE44277T1 (de) 1989-07-15
ES8604855A1 (es) 1986-03-01
ES546648A0 (es) 1986-03-01
DE3571240D1 (en) 1989-08-03
US4730069A (en) 1988-03-08
EP0174542B1 (de) 1989-06-28
DE3432320A1 (de) 1986-03-13
EP0174542A3 (en) 1987-05-06
JPH0730105B2 (ja) 1995-04-05
EP0174542A2 (de) 1986-03-19
JPS6169784A (ja) 1986-04-10
CA1268599A (en) 1990-05-01

Similar Documents

Publication Publication Date Title
DE3571240D1 (en) Cis-platinum-complexes having a pentaerythritol derivative as ligand, process for their preparation and pharmaceutical agent containing these compounds
NO174055C (no) Analogifremgangsmåte til fremstilling av cis-platina-komplekser
Rocek et al. The role of chromium (IV) in oxidations by chromic acid. The oxidative cleavage of cyclobutanol
FI904039A0 (fi) Kelatsbildare foer komplexering av radioaktiva isotoper, dess metallkomplexer och deras anvaendning i diagnostik och terapi.
DE3885557D1 (de) Neue Dicarbonsäure-bis(3,5-dicarbamoyl-2,4,6-Triiodanilide), Verfahren zu deren Herstellung sowie diese enthaltende Röntgenkontrastmittel.
JPS57145849A (en) Novel n-hydroxy-alkylated dicarboxylic acid-bis-(3,5-dicarbamoyl-2,4,6-triiodo- anilide), manufacture and contrast agent containing same
IE45225L (en) Dicarboxylic acid bis-(3,5-dicarbamoyl-2,4,6-triiodoanilide)¹compounds
US5112594A (en) Kit for preparing a technetium-99m myocardial imaging agent
TW376398B (en) Process for the preparation of hydrolysis-stable trivalent phosphorus compounds and their use as stabilizers for thermoplastics
US4917879A (en) 99MTC(III) myocardial imaging agents that are effective in humans
ES8604606A1 (es) Procedimiento para preparar complejos de cis-platino (ii) con derivados de diaminoazucar
US4957728A (en) Kit for preparing Tc (III)-99m myocardial imaging agents that are effective in humans
GB1412517A (en) Flame retardant acrylonitrile-butadiene-styrene polymeric composition
JPS5565956A (en) Developing solution for silver halide color photographic material
ES469804A1 (es) Procedimiento para la obtencion de nuevos compuestos de 6- amino-penam.
JPS56104813A (en) Composition for rectal infusion containing compound having beta-lactam ring
CH612671A5 (en) Process for producing new ethers
EP0058250A3 (de) Cephalosporinderivate, deren Herstellung und entsprechende pharmazeutische Präparate
Campestrini et al. Oxidation of alcohols and diols by peroxometal complexes
GR900100078A (el) Ενώσεις αλτρομυκίνης.
UST892001I4 (en) Defensive publication
EP0563328B1 (en) Tc(III)-99m MYOCARDIAL IMAGING AGENTS AND METHOD OF USE
KR910005870A (ko) 약제학적 제제
Kolar et al. ii New Patents
ATE28185T1 (de) Azetylenderivate mit enzyminhibierender wirkung, deren herstellung und deren verwendung als arzneimittel.